Compounds > s 12363
Page last updated: 2024-09-03

s 12363 and Neoplasms

s 12363 has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardiet, C; Clavel, M; Ings, RM; Lelièvre, E; Leyvraz, S; Lokiec, F; Lucas, C; Minaidis, D; Solere, P; Turpin, F1
Budman, DR1

Reviews

1 review(s) available for s 12363 and Neoplasms

ArticleYear
New vinca alkaloids and related compounds.
    Seminars in oncology, 1992, Volume: 19, Issue:6

    Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Drugs, Investigational; Humans; Lactones; Macrolides; Neoplasms; Vinblastine; Vinca Alkaloids; Vinorelbine

1992

Trials

1 trial(s) available for s 12363 and Neoplasms

ArticleYear
Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivative.
    Xenobiotica; the fate of foreign compounds in biological systems, 1992, Volume: 22, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Humans; Middle Aged; Neoplasms; Vinca Alkaloids

1992